Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000899243-23-006758

Chief Financial Officer sold 5,000 shares at $79.51 ($397,550)

  • Chief Financial Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gordon Stephen · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-01 Exercise or conversion : show line 1 in the form +5,000 $16.14 $80,700 23,789 D
2023-03-01 Sale : show line 2 in the form −5,000 $79.51 $397,550 18,789 D
Open-market sales · 5,000 sh · avg $79.51 · $397,550

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-01 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −5,000 15,728 D
Loading xslF345X03/doc4.xml…